We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cerebras Drops 20% in a Month: Is the Stock a Buy on the Dip?
Read MoreHide Full Article
Key Takeaways
CBRS shares fell 20.4% in a month amid OpenAI capacity delays, margin pressure & rising infrastructure costs.
CBRS' Q3 core revenues surged 70% to $230.9M, while cloud services revenues jumped 272% to $144.9M.
CBRS expects revenues to triple in 2027, backed by hyperscaler partnerships and growing AI inference demand.
Cerebras Systems (CBRS - Free Report) shares have dropped 20.4% in the past month, reflecting investor concerns over its OpenAI partnership, delays in AI data center capacity deployment, margin pressure and elevated infrastructure investments. The company continues to face stiff competition from NVIDIA (NVDA - Free Report) , Advanced Micro Devices (AMD - Free Report) and Intel (INTC - Free Report) in the AI space. However, strong demand for high-speed AI inference, expanding hyperscaler relationships and improving financial guidance suggest that the recent weakness could present a long-term buying opportunity. So, what should investors do with the stock? Let’s dig deep to find out.
CBRS’ Prospects Suffer From Data Center Delays
Concerns surrounding Cerebras’ relationship with OpenAI have been a major overhang on its shares. During the third-quarter 2026 earnings call, Cerebras acknowledged that insufficient data center capacity prevented a broader rollout of OpenAI’s Ultrafast offerings. CBRS management, however, rejected speculation that technical limitations were responsible and reiterated that OpenAI remains an important customer. The company disclosed delays in delivering portions of the contracted 750 megawatts of inference capacity, primarily due to land, power and building infrastructure constraints. Cerebras expects to return to its planned delivery schedule by the second half of 2027.
Profitability remains another concern for Cerebras. Despite reporting record third-quarter 2026 revenues, GAAP gross margin contracted to 20% from 40.6% in the year-ago quarter, reflecting a weaker hardware margin profile and accounting adjustments. Core hardware gross margin was 31%, pressured by shipments under older, lower-priced contracts. Meanwhile, the company reported a GAAP net loss of $161.2 million compared with $22.2 million in the prior-year quarter.
Cerebras’ prospects are suffering from stiff competition from the likes of NVIDIA (NVDA - Free Report) , Advanced Micro Devices (AMD - Free Report) and Intel (INTC - Free Report) in the AI space. NVIDIA is dominating the AI GPU market through its Blackwell, Hopper and DGX/NVL systems that are used for AI training and inference. AMD’s MI300 and MI350 accelerator families are competing with CBRS in hyperscale AI infrastructure and enterprise AI clusters. Meanwhile, Intel’s Gaudi AI accelerators target enterprise AI training and inference as a lower-cost GPU alternative. Shares of AMD, NVIDIA and Intel have dropped 0.8%, 30.2% and 40.4%, respectively, over the past month.
CBRS Stock’s Price Performance
Image Source: Zacks Investment Research
Cerebras shares are also trading at a premium, as suggested by the Value Score of D.
Moreover, Wall Street’s consensus price target implies roughly 143.04% average upside from current levels.
Image Source: Zacks Investment Research
Robust AI Inference Demand Aids CBRS’ Prospects
Cerebras continues to benefit from accelerating demand for high-speed AI inference solutions. In the third quarter of 2026, core revenues surged 70% year over year to $230.9 million, exceeding the company’s guidance midpoint by approximately 7%. Core cloud and other services revenues jumped 272% to $144.9 million, highlighting growing adoption of its inference platform. CBRS raised its fourth-quarter core revenue guidance to the $310-$330 million range and 2026 forecast to the $940-$960 million range. Cerebras also expects revenues to triple in 2027, supported by expanding cloud capacity, hardware shipments and stronger customer demand.
Cerebras’ expanding relationships with major cloud providers strengthen its long-term growth prospects and could reduce dependence on individual customers. The company secured partnerships with Amazon Web Services, Oracle and Microsoft, representing three hyperscaler wins over six months. Oracle plans to integrate Cerebras’ high-speed inference technology into Oracle Cloud Infrastructure, with service availability expected in summer 2027. Microsoft has also signed a cloud agreement, with additional details expected in 2027. Cerebras indicated that its opportunity pipeline increased by more than tenfold during the third quarter.
Cerebras’ expanding product portfolio and differentiated wafer-scale computing architecture remain important competitive advantages. The company’s CS-4 AI accelerator is approaching full production and is expected to double the performance and throughput of CS-3. The next-generation CS-5 system, powered by Wafer Scale Engine 5, is targeted for production in early summer 2027 and is designed to deliver more than twice the speed of CS-4. Cerebras has also introduced production-scale heterogeneous disaggregated inference using AMD GPUs alongside its proprietary systems. CBRS estimates that this architecture can increase token generation by up to fivefold per megawatt, potentially improving inference economics and data center profitability. Unlike competing GPU architectures, Cerebras’ systems do not require high-bandwidth memory, reducing exposure to memory shortages and associated cost inflation.
CBRS’ Estimate Revisions Show Improving Trend
The Zacks Consensus Estimate for CBRS’ 2026 earnings is pegged at 12 cents per share, against a loss of 36 cents per share over the past 30 days.
The consensus mark for fourth-quarter 2026 loss is pegged at 1 cent per share compared with a loss of 20 cents per share over the past 30 days.
Consensus Estimate Trend
Image Source: Zacks Investment Research
Conclusion: Here’s Why You Should Buy CBRS Stock
Cerebras’ recent share-price weakness reflects legitimate concerns over OpenAI capacity delivery delays, customer concentration, substantial infrastructure spending and persistent GAAP losses. These factors could sustain near-term volatility. Nevertheless, accelerating AI inference demand, growing hyperscaler adoption, expanding infrastructure capacity and an improving core profitability outlook provide a compelling long-term growth narrative. The company's differentiated technology and expectations of tripling revenues in 2027 strengthen the investment case. For investors comfortable with elevated execution and valuation risks, the recent pullback could represent an attractive opportunity to gain exposure to the expanding AI inference market.
Image: Bigstock
Cerebras Drops 20% in a Month: Is the Stock a Buy on the Dip?
Key Takeaways
Cerebras Systems (CBRS - Free Report) shares have dropped 20.4% in the past month, reflecting investor concerns over its OpenAI partnership, delays in AI data center capacity deployment, margin pressure and elevated infrastructure investments. The company continues to face stiff competition from NVIDIA (NVDA - Free Report) , Advanced Micro Devices (AMD - Free Report) and Intel (INTC - Free Report) in the AI space. However, strong demand for high-speed AI inference, expanding hyperscaler relationships and improving financial guidance suggest that the recent weakness could present a long-term buying opportunity. So, what should investors do with the stock? Let’s dig deep to find out.
CBRS’ Prospects Suffer From Data Center Delays
Concerns surrounding Cerebras’ relationship with OpenAI have been a major overhang on its shares. During the third-quarter 2026 earnings call, Cerebras acknowledged that insufficient data center capacity prevented a broader rollout of OpenAI’s Ultrafast offerings. CBRS management, however, rejected speculation that technical limitations were responsible and reiterated that OpenAI remains an important customer. The company disclosed delays in delivering portions of the contracted 750 megawatts of inference capacity, primarily due to land, power and building infrastructure constraints. Cerebras expects to return to its planned delivery schedule by the second half of 2027.
Profitability remains another concern for Cerebras. Despite reporting record third-quarter 2026 revenues, GAAP gross margin contracted to 20% from 40.6% in the year-ago quarter, reflecting a weaker hardware margin profile and accounting adjustments. Core hardware gross margin was 31%, pressured by shipments under older, lower-priced contracts. Meanwhile, the company reported a GAAP net loss of $161.2 million compared with $22.2 million in the prior-year quarter.
Cerebras’ prospects are suffering from stiff competition from the likes of NVIDIA (NVDA - Free Report) , Advanced Micro Devices (AMD - Free Report) and Intel (INTC - Free Report) in the AI space. NVIDIA is dominating the AI GPU market through its Blackwell, Hopper and DGX/NVL systems that are used for AI training and inference. AMD’s MI300 and MI350 accelerator families are competing with CBRS in hyperscale AI infrastructure and enterprise AI clusters. Meanwhile, Intel’s Gaudi AI accelerators target enterprise AI training and inference as a lower-cost GPU alternative. Shares of AMD, NVIDIA and Intel have dropped 0.8%, 30.2% and 40.4%, respectively, over the past month.
CBRS Stock’s Price Performance
Image Source: Zacks Investment Research
Cerebras shares are also trading at a premium, as suggested by the Value Score of D.
Moreover, Wall Street’s consensus price target implies roughly 143.04% average upside from current levels.
Image Source: Zacks Investment Research
Robust AI Inference Demand Aids CBRS’ Prospects
Cerebras continues to benefit from accelerating demand for high-speed AI inference solutions. In the third quarter of 2026, core revenues surged 70% year over year to $230.9 million, exceeding the company’s guidance midpoint by approximately 7%. Core cloud and other services revenues jumped 272% to $144.9 million, highlighting growing adoption of its inference platform. CBRS raised its fourth-quarter core revenue guidance to the $310-$330 million range and 2026 forecast to the $940-$960 million range. Cerebras also expects revenues to triple in 2027, supported by expanding cloud capacity, hardware shipments and stronger customer demand.
Cerebras’ expanding relationships with major cloud providers strengthen its long-term growth prospects and could reduce dependence on individual customers. The company secured partnerships with Amazon Web Services, Oracle and Microsoft, representing three hyperscaler wins over six months. Oracle plans to integrate Cerebras’ high-speed inference technology into Oracle Cloud Infrastructure, with service availability expected in summer 2027. Microsoft has also signed a cloud agreement, with additional details expected in 2027. Cerebras indicated that its opportunity pipeline increased by more than tenfold during the third quarter.
Cerebras’ expanding product portfolio and differentiated wafer-scale computing architecture remain important competitive advantages. The company’s CS-4 AI accelerator is approaching full production and is expected to double the performance and throughput of CS-3. The next-generation CS-5 system, powered by Wafer Scale Engine 5, is targeted for production in early summer 2027 and is designed to deliver more than twice the speed of CS-4. Cerebras has also introduced production-scale heterogeneous disaggregated inference using AMD GPUs alongside its proprietary systems. CBRS estimates that this architecture can increase token generation by up to fivefold per megawatt, potentially improving inference economics and data center profitability. Unlike competing GPU architectures, Cerebras’ systems do not require high-bandwidth memory, reducing exposure to memory shortages and associated cost inflation.
CBRS’ Estimate Revisions Show Improving Trend
The Zacks Consensus Estimate for CBRS’ 2026 earnings is pegged at 12 cents per share, against a loss of 36 cents per share over the past 30 days.
The consensus mark for fourth-quarter 2026 loss is pegged at 1 cent per share compared with a loss of 20 cents per share over the past 30 days.
Consensus Estimate Trend
Image Source: Zacks Investment Research
Conclusion: Here’s Why You Should Buy CBRS Stock
Cerebras’ recent share-price weakness reflects legitimate concerns over OpenAI capacity delivery delays, customer concentration, substantial infrastructure spending and persistent GAAP losses. These factors could sustain near-term volatility. Nevertheless, accelerating AI inference demand, growing hyperscaler adoption, expanding infrastructure capacity and an improving core profitability outlook provide a compelling long-term growth narrative. The company's differentiated technology and expectations of tripling revenues in 2027 strengthen the investment case. For investors comfortable with elevated execution and valuation risks, the recent pullback could represent an attractive opportunity to gain exposure to the expanding AI inference market.
Cerebras currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.